Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

[1]  J. Ribera.  Acute lymphoblastic leukemia in adults , 2011, Pediatric reports.

[2]  A. Hadnagy,et al.  Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics , 2008, Molecular Cancer Therapeutics.

[3]  Kevin Camphausen,et al.  Inhibition of histone deacetylation: a strategy for tumor radiosensitization. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[5]  H. M. Beier,et al.  Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis , 2005, Breast Cancer Research and Treatment.

[6]  G. Nicolson,et al.  Expression of the metastasis‐associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas , 2004, International journal of cancer.

[7]  L. Ngo,et al.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[9]  Kuang-Hung Cheng,et al.  Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code , 2003, Annals of the New York Academy of Sciences.

[10]  C. Cordon-Cardo,et al.  Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  C. Bloomfield,et al.  Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. , 1999, Blood.

[12]  R. Larson,et al.  A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. , 1995, Blood.

[13]  Ganser,et al.  Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. , 1988, Blood.

[14]  M. Andreeff,et al.  Acute lymphoblastic leukemia in adults. , 1985, Seminars in oncology.